Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | BRISTOL MEDICAMENTS | 1 | ₹8,741.58 |
| 2 | Schedule 2 | GULAB MEDICOSE | 1 | ₹2,568 |
| 3 | Schedule 3 | BRISTOL MEDICAMENTS | 1 | ₹6,787 |
| 4 | Schedule 4 | BRISTOL MEDICAMENTS | 1 | ₹193.80 |
| 5 | Schedule 5 | BRISTOL MEDICAMENTS | 1 | ₹16,133.04 |
Tender Value
₹48,215.52
EMD Value
Exempted
Closing Date
27 Sept 2024, 8:00 pmClosed
Drugs and
6874022
GEM/2024/B/5371903
Two Packet Bid
Antacid gel each 5ml containing dried aluminum hydroxide gel IP 250mg magnesium hydroxide 25mg and
30 days
Rajasthan; Kota
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹31
50%
Exempted
27 Sept 2024
6 Sept 2024
27 Sept 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Antacid gel each 5ml containing dried aluminum hydroxide gel IP 250mg magnesium hydroxide 25mg and methyl polysiloxane 50mg bottle of 170ml | 534 | Bott | KOTA CITY | 30 |
| 2 | Ciprofloxacin 0 point 3 percentage eye drop of 3mg per ml bott of 5 ml | 321 | Bott | KOTA CITY | 30 |
| 3 | Anti Venom serum polyvalent Dry vial of 10ml | 11 | Vial | KOTA CITY | 30 |
| 4 | Amlodipine besylate 5 mg Tablet | 1,020 | No | KOTA CITY | 30 |
| 5 | Typhoid Vaccine polysaccharide 0 point 5 ml Vial oblique PFS | 231 | Vial PFS | KOTA CITY | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6874022.pdf
GEM_BID
boq_re-02-1_2024-09-06-18-41-49_e5d068c342b589f44446c7cb713416bd.pdf
BOQ
boq_item_sample_file-2_2024-09-06-18-41-49_c90560de0e335211c6a0ea05340f6c3f.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .